ArticleHuman vaccines & immunotherapeutics2026
LILRB2 inhibition by blocking antibody ES009 reprograms immunosuppressive myeloid cells and enhances T-cell-mediated tumor immunity.
Xiaofeng Niu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.